View in EDS

Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD.

Saved in:
Bibliographic Details
Title: Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD.
Authors: Stevanovic M; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Koulisis N; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Retina Los Angeles, Los Angeles, CA, USA., Chen T; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA., Moysidis SN; Retina Los Angeles, Los Angeles, CA, USA., Burkemper B; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Toy BC; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Rao NA; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Eliott D; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA., Humayun MS; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; USC Ginsburg Institute for Biomedical Therapeutics, Los Angeles, CA, USA.
Source: Journal of vitreoretinal diseases [J Vitreoretin Dis] 2025 Apr 21; Vol. 9 (4), pp. 406-415. Date of Electronic Publication: 2025 Apr 21 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 101700301 Publication Model: eCollection Cited Medium: Internet ISSN: 2474-1272 (Electronic) Linking ISSN: 24741264 NLM ISO Abbreviation: J Vitreoretin Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40271423
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stevanovic+M%22">Stevanovic M</searchLink>; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Koulisis+N%22">Koulisis N</searchLink>; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Retina Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+T%22">Chen T</searchLink>; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moysidis+SN%22">Moysidis SN</searchLink>; Retina Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Burkemper+B%22">Burkemper B</searchLink>; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Toy+BC%22">Toy BC</searchLink>; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rao+NA%22">Rao NA</searchLink>; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Eliott+D%22">Eliott D</searchLink>; Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Humayun+MS%22">Humayun MS</searchLink>; USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; USC Ginsburg Institute for Biomedical Therapeutics, Los Angeles, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101700301%22">Journal of vitreoretinal diseases</searchLink> [J Vitreoretin Dis] 2025 Apr 21; Vol. 9 (4), pp. 406-415. <i>Date of Electronic Publication: </i>2025 Apr 21 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101700301 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2474-1272 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224741264%22">24741264 </searchLink><i>NLM ISO Abbreviation: </i>J Vitreoretin Dis <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40271423
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/24741264251332515
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 406
    Titles:
      – TitleFull: Intraocular Inflammation, Safety Events, and Outcomes After Intravitreal Injection of Ranibizumab, Aflibercept, Brolucizumab, Abicipar Pegol, and Faricimab for nAMD.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stevanovic M
      – PersonEntity:
          Name:
            NameFull: Koulisis N
      – PersonEntity:
          Name:
            NameFull: Chen T
      – PersonEntity:
          Name:
            NameFull: Moysidis SN
      – PersonEntity:
          Name:
            NameFull: Burkemper B
      – PersonEntity:
          Name:
            NameFull: Toy BC
      – PersonEntity:
          Name:
            NameFull: Rao NA
      – PersonEntity:
          Name:
            NameFull: Eliott D
      – PersonEntity:
          Name:
            NameFull: Humayun MS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 21
              M: 04
              Text: 2025 Apr 21
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2474-1272
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Journal of vitreoretinal diseases
              Type: main
ResultId 1